Literature DB >> 22969913

Comparative proteomic analysis of the function and network mechanisms of MASPIN in human lung cells.

Yao Liu1, Yi Geng, Kuanzhi Li, Fang Wang, Haiping Zhou, Wanhu Wang, Jie Hou, Wenchao Liu.   

Abstract

MASPIN, which is also known as Serpin B5, is a novel tumor suppressor. Emerging evidence suggests that MASPIN acts as a multifaceted protein in various types of cancer, including prostate, breast and pancreatic cancer. It interacts with diverse groups of intercellular and extracellular proteins, regulating cell adhesion, motility, apoptosis and angiogenesis, and is involved in mammary gland development. As MASPIN is a multifunctional factor in cancer pathways, its function remains poorly illuminated. In this study, we compared the protein profiles of LC5 cell lines with MASPIN overexpression and knockdown using comparative two-dimensional gel electrophoresis. The differences in protein expression, visualized as differences in spots, were identified by time-of-flight (TOF)/TOF mass spectometry. Significant differences were observed between overexpressing and knocked down cells, including eight spots that were unique and sixteen spots that were up- or down-regulated by more than 4-fold. Six genes, including Sdccag8, Ldoc1, SCAI, SDCCAG3, CT62 and NEDD9 were unique in MASPIN-expressing cell lines, but absent in knock-out cell lines, in which most of them play a significant role in the invasion of cancer cells. Moreover, the Brms1 and CAGE1 genes were identified as being uniquely expressed in knocked down cell lines, which were associated with the development and progression of tumors. The data from this study shed some light on the function, as well as the general network mechanisms of MASPIN in lung cancer.

Entities:  

Year:  2011        PMID: 22969913      PMCID: PMC3438607          DOI: 10.3892/etm.2011.427

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

Review 1.  Signaling through focal adhesion kinase.

Authors:  D D Schlaepfer; C R Hauck; D J Sieg
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

2.  Maspin inhibits cell migration in the absence of protease inhibitory activity.

Authors:  Rosemary Bass; Ana-María Moreno Fernández; Vincent Ellis
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

3.  Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.

Authors:  H Biliran; S Sheng
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Epigenetic regulation of maspin expression in the human placenta.

Authors:  Anuja Dokras; Jeremy Coffin; Lorie Field; Amanda Frakes; Hwahyung Lee; Anuradha Madan; Timothy Nelson; Gi-Yung Ryu; Jae-Geun Yoon; Anup Madan
Journal:  Mol Hum Reprod       Date:  2006-08-26       Impact factor: 4.025

5.  Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model.

Authors:  Heidi Y Shi; Rong Liang; Nancy S Templeton; Ming Zhang
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

6.  Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis.

Authors:  Koichi Nagasaki; Christian Schem; Constantin von Kaisenberg; Marco Biallek; Frank Rösel; Walter Jonat; Nicolai Maass
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

7.  Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer.

Authors:  Nicolai Maass; Marco Biallek; Frank Rösel; Christian Schem; Nobuyuki Ohike; Ming Zhang; Walter Jonat; Koichi Nagasaki
Journal:  Biochem Biophys Res Commun       Date:  2002-09-13       Impact factor: 3.575

8.  SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin.

Authors:  Dominique T Brandt; Christian Baarlink; Thomas M Kitzing; Elisabeth Kremmer; Johanna Ivaska; Peter Nollau; Robert Grosse
Journal:  Nat Cell Biol       Date:  2009-04-06       Impact factor: 28.824

9.  Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

Authors:  Michael L Cher; Hector R Biliran; Sunita Bhagat; Yonghong Meng; Mingxin Che; Jaron Lockett; Judith Abrams; Rafael Fridman; Michael Zachareas; Shijie Sheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

Review 10.  Modeling human breast cancer metastasis in mice: maspin as a paradigm.

Authors:  H Y Shi; W Zhang; R Liang; F Kittrell; N S Templeton; D Medina; M Zhang
Journal:  Histol Histopathol       Date:  2003-01       Impact factor: 2.303

View more
  4 in total

1.  Non-small-cell lung cancer pathological subtype-related gene selection and bioinformatics analysis based on gene expression profiles.

Authors:  Jiangpeng Chen; Xiaoqi Dong; Xun Lei; Yinyin Xia; Qing Zeng; Ping Que; Xiaoyan Wen; Shan Hu; Bin Peng
Journal:  Mol Clin Oncol       Date:  2017-11-27

2.  Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression.

Authors:  Chun-Te Wu; Wen-Ching Wang; Miao-Fen Chen; Hou-Yu Su; Wei-Yu Chen; Chih-Hsiung Wu; Yu-Jia Chang; Hui-Hsiung Liu
Journal:  Tumour Biol       Date:  2013-08-07

3.  Variation at ACOT12 and CT62 locus represents susceptibility to psoriasis in Han population.

Authors:  Jianxiao Xing; Xincheng Zhao; Xiaofang Li; Ying Wang; Junqin Li; Ruixia Hou; Xuping Niu; Guohua Yin; Xinhua Li; Kaiming Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-12-20       Impact factor: 2.183

4.  LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.

Authors:  Chia-Huei Lee; Kao-Lu Pan; Ya-Chu Tang; Ming-Hsien Tsai; Ann-Joy Cheng; Mei-Ya Shen; Ying-Min Cheng; Tze-Ta Huang; Pinpin Lin
Journal:  Oncotarget       Date:  2015-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.